These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1893749)

  • 1. Pharmacokinetic considerations for treatment of bacterial peritonitis during continuous ambulatory peritoneal dialysis.
    Bouchet JL; Aparicio M; Vinçon G; Demotes-Mainard F; Quentin C; Bourdenx JP; Dupoux J; Potaux L
    Contrib Nephrol; 1991; 89():96-107. PubMed ID: 1893749
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Petersen J; Stewart RD; Catto GR; Edward N
    Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with a combination of fosfomycin and pefloxacin].
    Michel C; Viron B; Delisle F; Lependoven C; Mignon F
    Pathol Biol (Paris); 1989 Apr; 37(4):269-71. PubMed ID: 2660079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intraperitoneal cefotaxime in children with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    Bald M; Rascher W; Bonzel KE; Müller-Wiefel DE
    Perit Dial Int; 1990; 10(4):311-3. PubMed ID: 2096939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
    Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
    Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritonitis in continuous ambulatory peritoneal dialysis. Making therapeutic decisions easier.
    Oreopoulos DG; Vas SI
    Arch Intern Med; 1987 May; 147(5):818-9. PubMed ID: 3579435
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiresistant Serratia marcescens peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) successfully treated with Azthreonam (S26,776) a new monobactam antibiotic.
    Hortling L; Sipilä R
    Clin Nephrol; 1984 Jun; 21(6):355. PubMed ID: 6380850
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Leblanc M
    Clin Nephrol; 1997 May; 47(5):350. PubMed ID: 9181286
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
    Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
    Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in continuous ambulatory peritoneal dialysis.
    Spencer RC
    J Med Microbiol; 1988 Sep; 27(1):1-9. PubMed ID: 3050104
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
    Fenton P
    J Clin Pathol; 1982 Nov; 35(11):1181-4. PubMed ID: 6754760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
    Ragnaud JM; Roche-Bezian MC; Dupon M; Wone C
    Chemioterapia; 1987 Jun; 6(2 Suppl):481-3. PubMed ID: 3509476
    [No Abstract]   [Full Text] [Related]  

  • 13. Ambulatory peritonitis.
    Lancet; 1982 May; 1(8281):1104-5. PubMed ID: 6122896
    [No Abstract]   [Full Text] [Related]  

  • 14. Fungal peritonitis in continuous ambulatory peritoneal dialysis.
    Saran R; Goel S; Khanna R
    Int J Artif Organs; 1996 Aug; 19(8):441-5. PubMed ID: 8841840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefotaxime in chronic renal insufficiency].
    Federico S; Fuiano G; Andreucci VE
    G Ital Chemioter; 1985; 32(2):325-8. PubMed ID: 3833574
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative therapy for the infections of the peritoneal catheter tunnel during C.A.P.D.
    Lombardo V; Bordoni E; Bibiano L; Micucci G; Castelli P; Radicioni R; Tarchini R; Boggi R; Perilli A; Mioli V
    Life Support Syst; 1985; 3 Suppl 1():112-5. PubMed ID: 3916609
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
    Eyal A; Greif F; Shalit I; Lelcuk S
    Isr J Med Sci; 1996 Dec; 32(12):1317-9. PubMed ID: 9007180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed organism peritonitis complicating continuous ambulatory peritoneal dialysis.
    O'Connor J; MacCormick DE
    N Z Med J; 1982 Nov; 95(720):811-2. PubMed ID: 6961320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.